Myriad Genetics Inc (MYGN)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Jun 30, 2020 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | -2,200 | 90,900 | 231,900 | -54,000 | 211,500 |
| Revenue | US$ in thousands | 745,400 | 675,200 | 846,000 | 627,800 | 840,000 |
| Gross profit margin | -0.30% | 13.46% | 27.41% | -8.60% | 25.18% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $-2,200K ÷ $745,400K
= -0.30%
The gross profit margin of Myriad Genetics, Inc. has exhibited a decreasing trend over the past five years. In particular, the gross profit margin decreased from 76.38% as of June 30, 2019, to 68.64% as of December 31, 2023. This downward trend may indicate potential challenges in maintaining profitability on the company's core operations, such as managing production costs or pricing pressures. Further analysis and comparisons with industry averages would be necessary to fully understand the implications of this declining trend on the company's financial performance and competitiveness in the market.
Peer comparison
Dec 31, 2023